ArticleThoracic cancer2023

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.

Koichiro Kanamori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.